INTECH Investment Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
INTECH Investment Management's ABBV Position: Q2 2026 in Review
INTECH Investment Management reduced its AbbVie (ABBV) stake by 7.1% in Q2 2026, selling an estimated $758K and leaving 46,148 shares worth $11.6M. The position accounts for 0.11% of the portfolio, ranked #161.
INTECH Investment Management first reported a position in ABBV in Q2 2022 and has held it in 17 quarters since. The position peaked at $163M in Q1 2023. 4,217 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- INTECH Investment Management held 46,148 shares of AbbVie worth $11.6M as of Q2 2026.
- INTECH Investment Management sold 3,525 AbbVie shares in Q2 2026, an estimated $758K.
- AbbVie made up 0.11% of INTECH Investment Management's portfolio in Q2 2026, its #161 holding.
- INTECH Investment Management first reported a position in AbbVie in Q2 2022 and has held it in 17 quarters since.
- INTECH Investment Management's AbbVie position peaked at $163M in Q1 2023.
- 4,217 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.